Omesa Drugs And Chemicals Private Limited, a active private limited company, was established on 07 May 2015 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299PN2015PTC154949. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Sanjay Suresh Sawant (Director), Prakash Dadu Patil (Director), Gitanjali Sanjay Sawant (Director). Past directors included Suresh Manakchand Paharia, Suresh Somchand Shah. It holds ₹2.27 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.C-102, Ganesh Nabhangan,B-20 Raikar Nagar, Wadgaon, Dhayari, Pune, Maharashtra, 411041.
U24299PN2015PTC154949
154949
07 May 2015
₹5.00 M
₹5.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Omesa Drugs And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Suresh Sawant | Director | 07 May 2015 | Current |
| Prakash Dadu Patil | Director | 01 Feb 2018 | Current |
| Gitanjali Sanjay Sawant | Director | 07 May 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 May 2024 | Past |
| Pramod Abcsdd | Director | 24 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omesa Drugs And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.33% decrease. The company also saw a substantial fall in profitability, with a 1934.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 55.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Omesa Drugs And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹22,650,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2023 | Others | ₹2.80 M | Open |
| 28 Jun 2021 | State Bank Of India | ₹9.25 M | Open |
| 09 Dec 2020 | Others | ₹9.40 M | Open |
| 09 Dec 2020 | Others | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Omesa Drugs And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Omesa Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omesa Drugs And Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Omesa Drugs And Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Omesa Drugs And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
A charge with Others amounted to Rs. 2.80 M with Charge ID 100746932 was registered on 30 May 2023. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 9.25 M with Charge ID 100466110 was registered on 28 Jun 2021. was documented.
Progress on A charge with Others amounted to Rs. 9.40 M with Charge ID 100399807 was registered on 09 Dec 2020. was documented.
Progress on A charge with Others amounted to Rs. 1.20 M with Charge ID 100400044 was registered on 09 Dec 2020. was documented.
The CIN of Omesa Drugs And Chemicals Private Limited is U24299PN2015PTC154949.
Omesa Drugs And Chemicals Private Limited is headquartered at Flat No.C-102, Ganesh Nabhangan,B-20 Raikar Nagar, Wadgaon, Dhayari, Pune, Maharashtra, 411041.
Omesa Drugs And Chemicals Private Limited was incorporated on 07 May 2015.
The current directors of Omesa Drugs And Chemicals Private Limited are
The primary industry of Omesa Drugs And Chemicals Private Limited is Manufacturing.
Omesa Drugs And Chemicals Private Limited is unlisted.
The authorized capital of Omesa Drugs And Chemicals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Omesa Drugs And Chemicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX